Furey Raymond J. 4
4 · RIGEL PHARMACEUTICALS INC · Filed Sep 17, 2025
Insider Transaction Report
Form 4
Furey Raymond J.
EVP, GC, CCO & Corp Sec
Transactions
- Award
Employee Stock Option (right to buy)
2025-09-15+7,394→ 7,394 totalExercise: $22.49Exp: 2035-01-29→ Common Stock (7,394 underlying)
Footnotes (2)
- [F1]The Reporting Person was granted a stock option with a performance-based condition with respect to 7,394 shares of the Issuer's common stock on January 29, 2025. The exercise price of this option is $22.49, which is the closing price of the Issuer's common stock on Nasdaq on the date of grant. In light of the performance-based vesting condition, this grant was not reportable under Section 16 until the performance metric was satisfied. On September 15, 2025, it was determined that the performance metric had been met.
- [F2]The option was fully vested on September 15, 2025, the date the determination was made that the performance metric had been met.